Montelukast Teva (Montelukast Sodium)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor type 1 (CysLT1). This inhibition prevents leukotrienes from triggering bronchoconstriction, mucus production and vascular leakage, thereby improving airflow in the lungs and reducing inflammation in the nasal passages.

The dose of Montelukast is individualized by the prescribing healthcare professional based on the patient’s age, weight and specific indication. Typical regimens differ for asthma, allergic rhinitis and exercise‑induced bronchoconstriction, and patients should follow the prescriber’s instructions without self‑adjusting the dose.

The pregnancy category for Montelukast is listed as unknown. It should only be used during pregnancy or lactation if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy or breastfeeding should discuss the decision with their healthcare provider.

To place an order, submit an enquiry on the Montelukast Teva product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Montelukast belongs to the leukotriene receptor antagonist class, which provides an oral option for asthma and allergic rhinitis. Compared with inhaled corticosteroids, it is less potent for controlling severe asthma but offers a convenient once‑daily tablet form and can be used as add‑on therapy. Unlike antihistamines, it specifically targets leukotriene‑driven inflammation rather than histamine pathways.

Montelukast Teva should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and avoid storing it in areas with high humidity or temperature fluctuations to maintain potency.

Montelukast is typically supplied as oral tablets (or granules) that are taken once daily, with or without food, as directed by the prescriber. The medication is swallowed whole and should not be chewed or crushed unless a specific formulation advises otherwise.

Serious risks include neuropsychiatric events such as depression, suicidal thoughts or behavior, severe allergic reactions like angioedema, and potential liver injury indicated by elevated hepatic enzymes. Patients should seek immediate medical attention if they experience mood changes, swelling of the face or throat, or signs of liver dysfunction such as jaundice.

Montelukast should not be used by individuals with a known hypersensitivity to Montelukast sodium or any of the tablet’s excipients. Caution is also advised for patients with severe hepatic impairment, and it is generally avoided in those who have experienced serious neuropsychiatric reactions to leukotriene antagonists.